Silymarin, an extract of the seeds of milk thistle [Silybum marianum (L.) Gaertn. (Asteraceae)] protects liver cells from virus infection, oxidative stress,
and inflammation. It was hypothesized that silymarin provides hepatoprotection by
binding to cellular proteins. The hypothesis was addressed by establishing an affinity-based
system for capturing, identifying, and validating the cellular proteins bound by the
flavonolignan mixture silibinin, a major bioactive component of silymarin. Diazirine
or diphenylketone photoreactive groups and alkyne or azide moieties were chemically
engineered onto eleven derivatives of silybin A or silibinin. Toxicity and anti-hepatitis
C virus (HCV) activity testing of probes on human hepatoma cells indicated that all
probes had antiviral activity that was separable from compound-induced toxicity. Probes
were then used to capture cellular proteins from hepatoma cells. Mass spectrometry
and statistical filtering revealed 26 putative cellular protein targets, which specifically
bound to a photoaffinity probe. Binding of the probe to protein targets was dose-dependently
inhibited by silybin A. Descriptions of the putative targets, along with chemical
validation of the interaction of silibinin with the targets, will be presented. The
approach should permit further unraveling of the complex biology arising when cells
encounter natural products.